Clinical Trials on Akselerert fase kronisk myelogen leukemi, BCR-ABL1 positiv in Liechtenstein
Totalt 0 resultater
Ingenting funnet
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.
Sponsorer og samarbeidspartnere
- University Hospital, Udine, Italy
- Centrum voor Kankeropsporing
- Rogerio A. Lobo
- Great Ormond Street Hospital for Children NHS Foundation Trust
- Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI)
- Trialbureau Zorgevaluatie Nederland
- AFDPHE
- Oulu Deaconess Institute
- Left Coast Engineering, Escondido
- Avonova
- Interregionale Blutspende SRK
- José Roberto Filassi
- Georgia Research Alliance
- People's Hospital of Ganzhou City
- Mireia Merichal
- Centre Hospitalier Intercommunal Villeneuve St Georges
- Conde, Bebiana, M.D.
- Institute of Genetics and Biophysics CNR
- Italian Association of Hospital Pneumologists
- Société Française de Recherche et Médecine du Sommeil
- Vis full liste
Medisinsk tilstand
- Mikrovaskulær sjeldne reaksjon
- Ano Fistel
- Barndom akutt minimalt differensiert myeloid leukemi (M0)
- Grad B akutt graft versus vertssykdom
- Venøs overbelastning
- Lumbal spinal stenose med nattlige leggkramper
- Re-entrerende atrioventrikulær takykardi
- Eosinofil øsofagitt (EoE)
- Overlevelse etter IPA
- SCC - plateepitelkarsinom i huden
- EBV-relatert sarkom
- Keratosis Pilaris (KP)
- Dyp venetrombose proksimalt
- Obskur gastrointestinal blødning (okkult eller åpenlyst)
- Luftveier; Obstruksjon, med emfysem
- Sykehusrelatert funksjonshemming
- Kroniske magesmerter
- Genetikk populasjon
- Rektalt fremmedlegeme
- Helseforsikring ustabilitet
- Vis full liste
Legemiddelintervensjoner
- Dacomitinib
- Custodiol løsning
- PEG-G-CSF
- Lorazepam
- 1500 ppm MFP/CaCO3 1,16 % natriummonofluorfosfat) Tannpleiemiddel
- Rituximab
- Rivastigmin
- Oksaliplatin
- Divalproex (DIV) ER
- Triptorelin (Decapeptyl®, Ipsen Pharma, Barcelona, Spania)
- 177Lu-DOTATOC
- Alkohol
- Fidaxomicin
- DCDT2980S
- Prasugrel
- Obinutuzumab
- JNJ-63623872
- 20 mg PF-02545920
- Durvalumab - 1500 mg
- Epinefrin (topisk administrering)
- Vis full liste
CROs by country
- Contract Research Organizations in Brazil
- Contract Research Organizations in Burundi
- Contract Research Organizations in Croatia
- Contract Research Organizations in Egypt
- Contract Research Organizations in Guinea
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Panama
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Philippines
- Contract Research Organizations in Qatar
- Contract Research Organizations in Romania
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Vietnam
- CRO list by country